Department of Health and Social Care (DHSC) has issued a medicine supply notification for Tresiba Flextouch 100units/ml solution for injection 3ml pre-filled pens

Information is available on website: Medicine Supply Notification: Tresiba (insulin degludec) FlexTouch – Community Pharmacy England (cpe.org.uk)

Date of issue 24th May 2023

• Tresiba^® FlexTouch^® (Insulin degludec) 100units/ml pens will be out of stock from August 2023 until January 2024.
• Tresiba Penfill^® (Insulin degludec) 100units/ml solution for injection 3ml cartridges remain available and can support increased demand.

Update from Novo Nordisk on Fiasp® FlexTouch® supply

• Novo Nordisk UK is aware of a temporary stock shortage of Fiasp^® (fast-acting insulin aspart) FlexTouch^® pre-filled insulin pens in the UK. Other presentations of Fiasp^® are unaffected.
• There has been a delay in our next delivery of Fiasp® FlexTouch^®, which we expect to arrive in a matter of weeks. The shortage is not a consequence of any safety or quality related concern with Fiasp^® FlexTouch^®.
• Ensuring a continuous supply that meets the needs of patients and the NHS is of utmost importance for Novo Nordisk and we are engaging with the Department of Health & Social Care on this issue and working hard so that the next delivery arrives as soon as possible in the UK.
• During this temporary shortage period, healthcare professionals have the option to consider swapping to a suitable alternative for impacted patients, if deemed clinically appropriate.
• We ask that healthcare professionals continue to prescribe in the normal way to ensure stockpiling does not take place. This will allow us to plan our stock levels and to distribute our medicines and treatments in a normal way, so that people can continue to receive their treatment when the shortage is resolved.